FBR Capital Upgrades Core Laboratories (CLB) to Outperform on 'Very Strong' Q4
Tweet Send to a Friend
FBR Capital upgraded Core Laboratories (NYSE: CLB) from Market Perform to Outperform with a price target of $150.00 (from $110.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
